* | Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119791 Search Results for

*

Sort by

Sort Order Select

Journal Articles

Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)

Blood (2024) 144 (Supplement 2): LBA-1.

https://doi.org/10.1182/blood-2024-212970

Published: 2024

Journal Articles

Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis

Laurent Martin, Darko Maric, Salam Idriss, Marine Delamare, Amandine Le Roy, Nada Maaziz, Amandine Caillaud, Karim Si-Tayeb, Florence Robriquet, Marion Lenglet, Lucie Erceau, Christine Bellanné-Chantelot, Isabelle Plo, Bernard Aral, Céline Garrec, Fabrice Airaud, Clara Gianfermi, Vincent Antunes, Anna Keppner, Sarah Mathilda Vincent, Alexis Desfontaine, Nina Modé, Fabien Laporte, Anne Gaignerie, Caroline Chariau, Isabelle Leray, Coline Rogue, Laurent David, Richard Redon, Stephane Bezieau, Lamisse Mansour, Frederic Galacteros, Thibault Maillet, Marlène Pasquet, Pierre Cougoul, Anne-Marie Nloga, Claude Gardin, Corinne Guitton, Viviane Dubruille, Vannina Giacobbi-Milet, Thierry Leblanc, Zuhre Kaya, Denis Semama, Chloe James, Serge Carillo, Marlène Ochmann, Anders Waage, Erwan Mortier, Mike Maillasson, Agnès Quéméner, Holger Cario, Radek C. Skoda, Yaël Zermati, David Hoogewijs, Alexandre Marchand, Francois Girodon, Betty Gardie

Blood (2024) 144 (Supplement 2): LBA-2.

https://doi.org/10.1182/blood-2024-213000

Published: 2024

Journal Articles

Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

Francis Couturaud, Olivier Sanchez, Nicolas Meneveau, Laurent Bertoletti, Gilles Pernod, Isabelle Mahe, Emilie Presles, Philippe Girard, Cécile Tromeur, Patrick Mismetti, Silvy Laporte, Christophe Leroyer

Blood (2024) 144 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2024-212912

Published: 2024

Journal Articles

Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Jihyun Song, Soo Jin Kim, Josef T. Prchal

Blood (2024) 144 (Supplement 2): LBA-4.

https://doi.org/10.1182/blood-2024-213103

Published: 2024

Journal Articles

Outcome of Cerebral Vasculopathy and Cognitive Performances 10 Years Post-Enrollment in the Drepagreffe Trial Comparing Allogeneic Stem Cell Transplantation to Standard-Care in Children with Sickle Cell Anemia and History of Abnormal Cerebral Velocities

Blood (2024) 144 (Supplement 2): LBA-5.

https://doi.org/10.1182/blood-2024-212967

Published: 2024

Journal Articles

Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial

Blood (2024) 144 (Supplement 2): LBA-6.

https://doi.org/10.1182/blood-2024-212973

Published: 2024

Journal Articles

Deficit of microRNA (miR)-142 Promotes Transformation of Clonal Myeloid Disorder into Acute Myeloid Leukemia (AML)

Yongfang Xu, Huafeng Wang, Fang Chen, Jihyun Irizarry, Shawn Sharkas, Dandan Zhao, Mark Boldin, Guido Marcucci, Bin Zhang

Blood (2024) 144 (Supplement 1): 348.

https://doi.org/10.1182/blood-2024-211467

Published: 2024

Journal Articles

Increased Fiber Intake Results in Better Overall Survival and Lower GI-aGVHD in Allo-HCT Recipients and Pre-Clinical Gvhd Models

Jenny Paredes, Teng Fei, Anqi Dai, Ruben Ramos, Peter Adintori, Anastasia Kousa, Chi L Nguyen, Kristen Victor, Romina Ghale, Charlotte Pohl, Harold K Elias, Oriana Miltiadous, Sebastien Monette, Ana Gradissimo, Justin Cross, Jonathan U. Peled, Marina Burgos da Silva, Marcel R.M. van den Brink

Blood (2024) 144 (Supplement 1): 259.

https://doi.org/10.1182/blood-2024-204399

Published: 2024

Journal Articles

Daratumumab-Based Quadruplet Versus Triplet Induction Regimens in Frontline Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Joao Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan De Queiroz Crusoe, Vania Hungria, Angelo Maiolino

Blood (2024) 144 (Supplement 1): 258.

https://doi.org/10.1182/blood-2024-202677

Published: 2024

Journal Articles

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano J. Costa

Blood (2024) 144 (Supplement 1): 257.

https://doi.org/10.1182/blood-2024-205611

Published: 2024

Journal Articles

Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study

Blood (2024) 144 (Supplement 1): 256.

https://doi.org/10.1182/blood-2024-199374

Published: 2024

Journal Articles

A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma

Craig C. Hofmeister, Vikas A. Gupta, Jonathan L. Kaufman, Ajay K. Nooka, Nisha S. Joseph, Sagar Lonial, Madhav V. Dhodapkar

Blood (2024) 144 (Supplement 1): 255.

https://doi.org/10.1182/blood-2024-202102

Published: 2024

Journal Articles

Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)

Blood (2024) 144 (Supplement 1): 254.

https://doi.org/10.1182/blood-2024-210725

Published: 2024

Journal Articles

Evolution of Clonal Hematopoiesis after Discontinuation of Therapy for Multiple

Jennifer H Cooperrider, Diren Arda Arda Karaoglu, Tadeusz Kubicki, Ken Jiang, Ella Postich, Kathryn Kimi Shimamoto, Olivia Arnold, Aubrianna Ramsland, Anna Pula, Jommel Macaraeg, Andrzej J Jakubowiak, Benjamin A Derman, Caner Saygin

Blood (2024) 144 (Supplement 1): 253.

https://doi.org/10.1182/blood-2024-208256

Published: 2024

Journal Articles

Circulating Tumor DNA As a Minimally Invasive Predictor of Early Relapse in Multiple Myeloma

Palak Bajaj, Ola Landgren, Damian J. Green, David G. Coffey

Blood (2024) 144 (Supplement 1): 252.

https://doi.org/10.1182/blood-2024-204426

Published: 2024

Journal Articles

The Fetal Specific Gene LIN28B Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia

Rebecca E Ling, Thomas Jackson, Natalina Elliott, Joe W Cross, Lucy Hamer, Arundhati S Wuppalapati, Alastair L Smith, Catherine M Chahrour, Okan Sevim, Deena Iskander, Guanlin Wang, Sorcha I O'Byrne, Siobhan Rice, Joe R Harman, Bethan Psaila, Rhys G Morgan, Irene Roberts, Thomas A Milne, Anindita Roy

Blood (2024) 144 (Supplement 1): 199.

https://doi.org/10.1182/blood-2024-198819

Published: 2024

Journal Articles

CD74 Signaling Regulates Inflammatory Stress to Drive Defective Hematopoiesis and Fitness Advantage of Progenitors in RUNX1-Familial Platelet Disorder

Blood (2024) 144 (Supplement 1): 198.

https://doi.org/10.1182/blood-2024-211542

Published: 2024

Journal Articles

PARP Inhibitor Treatment Increases DNA Damage in Bone Marrow and Drives Compensatory Changes in Multiple Hematopoietic Stem and Progenitor Cell Populations Contingent on Brca1 Genotype

Sarah Obregon, Dalton McLean, Sarah Miller, Amer Mohiuddin, Heather Hardin, Fauzia Hollnagel, Jane E Churpek

Blood (2024) 144 (Supplement 1): 197.

https://doi.org/10.1182/blood-2024-207931

Published: 2024

Journal Articles

Modeling GATA2 Deficiency in Mice: The R396Q Mutation Disrupts Normal Hematopoiesis

Trent D Hall, Rashid Mehmood, Diana Sa da Bandeira, Anitria Cotton, Jonathon Klein, Shondra M Pruett-Miller, Shai Izraeli, Wilson K Clements, John D. Crispino

Blood (2024) 144 (Supplement 1): 196.

https://doi.org/10.1182/blood-2024-205815

Published: 2024

Journal Articles

Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma

Michael P. Agius, Laura Hevenor, N Connor Payne, Qi Liu, Hyuk-Soo Seo, Romanos Sklavenitis-Pistofidis, Daniel Heilpern-Mallory, Puspalata Bashyal, Michelle P. Aranha, Elizabeth D. Lightbody, Ralph Mazitschek, Sirano Dhe-Paganon, Jun Qi, Irene Ghobrial

Blood (2024) 144 (Supplement 1): 155.

https://doi.org/10.1182/blood-2024-203381

Published: 2024

NARROW

*

Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)

Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis

Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Outcome of Cerebral Vasculopathy and Cognitive Performances 10 Years Post-Enrollment in the Drepagreffe Trial Comparing Allogeneic Stem Cell Transplantation to Standard-Care in Children with Sickle Cell Anemia and History of Abnormal Cerebral Velocities

Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial

Deficit of microRNA (miR)-142 Promotes Transformation of Clonal Myeloid Disorder into Acute Myeloid Leukemia (AML)

Increased Fiber Intake Results in Better Overall Survival and Lower GI-aGVHD in Allo-HCT Recipients and Pre-Clinical Gvhd Models

Daratumumab-Based Quadruplet Versus Triplet Induction Regimens in Frontline Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study

A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma

Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)

Evolution of Clonal Hematopoiesis after Discontinuation of Therapy for Multiple

Circulating Tumor DNA As a Minimally Invasive Predictor of Early Relapse in Multiple Myeloma

The Fetal Specific Gene LIN28B Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia

CD74 Signaling Regulates Inflammatory Stress to Drive Defective Hematopoiesis and Fitness Advantage of Progenitors in RUNX1-Familial Platelet Disorder

PARP Inhibitor Treatment Increases DNA Damage in Bone Marrow and Drives Compensatory Changes in Multiple Hematopoietic Stem and Progenitor Cell Populations Contingent on Brca1 Genotype

Modeling GATA2 Deficiency in Mice: The R396Q Mutation Disrupts Normal Hematopoiesis

Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

*

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only